Trials / Terminated
TerminatedNCT03955835
Acandis Credo Intracranial Stent for Unsuccessful Recanalization After Thrombectomy (ACUTE)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Acandis GmbH · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Study objective is to evaluate the efficacy and safety of acute permanent stenting of symptomatic intracranial stenosis following unsuccessful recanalization by thrombectomy in acute ischemic stroke with large vessel occlusion using the self-expandable Credo® stent together with the NeuroSpeed® PTA balloon catheter.
Detailed description
Prospective, interventional treatment, single-arm, open-label, multi-center trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Treatment with Credo® stent together with the NeuroSpeed® PTA balloon catheter. | Self-expandable Credo® stent together with NeuroSpeed® PTA balloon catheter. Credo® and NeuroSpeed® are already CE approved products, for which within ACUTE an additional new indication shall be examined. |
Timeline
- Start date
- 2019-08-09
- Primary completion
- 2021-09-22
- Completion
- 2021-09-22
- First posted
- 2019-05-20
- Last updated
- 2021-10-21
Locations
8 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03955835. Inclusion in this directory is not an endorsement.